Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Phosphatidylserine Stimulates Ceramide 1-Phosphate (C1P) Intermembrane Transfer by C1P Transfer Proteins
  2. Zhai, Xiuhong; Gao, Yong-Guang; Mishra, Shrawan K.; Simanshu, Dhirendra; Boldyrev, Ivan A.; Benson, Linda M.; Bergen, H. Robert; Malinina, Lucy; Mundy, John; Molotkovsky, Julian G.; Patel, Dinshaw J.; Brown, Rhoderick E.
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2017, Feb 10; 292(6): 2531-2541.
  1. 2.   Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation
  2. Schmid, T.; Bajer, M. M.; Blees, J. S.; Eifler, L. K.; Milke, L.; Rubsamen, D.; Schulz, K.; Weigert, A.; Baker, A. R.; Colburn, N. H.; Brune, B.
  3. Carcinogenesis. 2011, Oct; 32(10): 1427-1433.
  1. 3.   Prevalence and Significance of Plasmid Maintenance Functions in the Virulence Plasmids of Pathogenic Bacteria
  2. Sengupta, M.; Austin, S.
  3. Infection and Immunity. 2011, Jul; 79(7): 2502-2509.
  1. 4.   Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluation
  2. Romagnoli, R.; Baraldi, P. G.; Cruz-Lopez, O.; Cara, C. L.; Carrion, M. D.; Balzarini, J.; Hamel, E.; Basso, G.; Bortolozzi, R.; Viola, G.
  3. Bioorganic & Medicinal Chemistry Letters. 2010, May; 20(9): 2733-2739.
  1. 5.   Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?
  2. Young, M. R.; Santhanam, A. N.; Yoshikawa, N.; Colburn, N. H.
  3. Molecular Interventions. 2010, Apr; 10(2): 76-79.
  1. 6.   Development of a High-Throughput Cell-Based Reporter Assay to Identify Stabilizers of Tumor Suppressor Pdcd4
  2. Blees, J. S.; Schmid, T.; Thomas, C. L.; Baker, A. R.; Benson, L.; Evans, J. R.; Goncharova, E. I.; Colburn, N. H.; McMahon, J. B.; Henrich, C. J.
  3. Journal of Biomolecular Screening. 2010, Jan; 15(1): 21-29.
  1. 7.   Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation
  2. Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cruz-Lopez, O.; Cara, C. L.; Balzarini, J.; Hamel, E.; Canella, A.; Fabbri, E.; Gambari, R.; Basso, G.; Viola, G.
  3. Bioorganic & Medicinal Chemistry Letters. 2009 19(7): 2022-2028.
  1. 8.   Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors
  2. Leupold, J. H.; Yang, H. S.; Colburn, N. H.; Asangani, I.; Post, S.; Allgayer, H.
  3. Oncogene. 2007, Jul; 26(31): 4550-4562.
  1. 9.   Enzymes of sphingolipid metabolism in Drosophila melanogaster
  2. Acharya, U.; Acharya, J. K.
  3. Cellular and Molecular Life Sciences. 2005, JAN; 62(2): 128-142.
  1. 10.   Interplay between plasmid partition and postsegregational killing systems
  2. Brendler, T.; Reaves, L.; Austin, S.
  3. Journal of Bacteriology. 2004 186(8): 2504-2507.
  1. 11.   GLIS3, a novel member of the GLIS subfamily of Kruppel-like zinc finger proteins with repressor and activation functions
  2. Kim, Y. S.; Nakanishi, G.; Lewandoski, M.; Jetten, A. M.
  3. Nucleic Acids Research. 2003 31(19): 5513-5525.
  1. 12.   Regulation of apoptosis: the ubiquitous way
  2. Yang, Y. L.; Yu, X. D.
  3. Faseb Journal. 2003 17(8): 790-799.
  1. 13.   Effect of bcl-2 on the primordial follicle endowment in the mouse ovary
  2. Flaws, J. A.; Hirshfield, A. N.; Hewitt, J. A.; Babus, J. K.; Furth, P. A.
  3. Biology of Reproduction. 2001 64(4): 1153-1159.
  1. 14.   RNA folding pathway functional intermediates: Their prediction and analysis
  2. Shapiro, B. A.; Bengali, D.; Kasprzak, W.; Wu, J. C.
  3. Journal of Molecular Biology. 2001 312(1): 27-44.
  1. 15.   From cytosol to mitochondria: The Bax translocation story
  2. Khaled, A. R.; Durum, S. K.
  3. Journal of Biochemistry and Molecular Biology. 2001 34(5): 391-394.
  1. 16.   Phenotypic and functional change of cytokine-activated neutrophils: inflammatory neutrophils are heterogeneous and enhance adaptive immune responses
  2. Yamashiro, S.; Kamohara, H.; Wang, J. M.; Yang, D.; Gong, W. H.; Yoshimura, T.
  3. Journal of Leukocyte Biology. 2001 69(5): 698-704.
  1. 17.   Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-x(L) protein levels
  2. Tudor, G.; Aguilera, A.; Halverson, D. O.; Laing, N. D.; Sausville, E. A.
  3. Cell Death and Differentiation. 2000 7(6): 574-586.
  1. 18.   Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage
  2. Shibata, M. A.; Liu, M. L.; Knudson, M. C.; Shibata, E.; Yoshidome, K.; Bandey, T.; Korsmeyer, S. J.; Green, J. E.
  3. Embo Journal. 1999 18(10): 2692-2701.
  1. 19.   MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-alpha plays a role in maximal MCP-1 mRNA expression
  2. Yamashiro, S.; Kamohara, H.; Yoshimura, T.
  3. Journal of Leukocyte Biology. 1999 65(5): 671-679.
  1. 20.   Mechanisms of p53-mediated apoptosis
  2. Bates, S.; Vousden, K. H.
  3. Cellular and Molecular Life Sciences. 1999 55(1): 28-37.
  1. 21.   Similar Levels of Human Immunodeficiency Virus Type 1 Replication in Human T(H)1 and T(H)2 Clones
  2. Mikovits, J. A.; Taub, D. D.; Turcovskicorrales, S. M.; Ruscetti, F. W.
  3. Journal of Virology. 1998 72(6): 5231-5238.
  1. 22.   IAP-family protein Survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
  2. Tamm, I.; Wang, Y.; Sausville, E.; Scudiero, D. A.; Vigna, N.; Oltersdorf, T.; Reed, J. C.
  3. Cancer Research. 1998 58(23): 5315-5320.
  1. 23.   Identification and Mapping of Casp7, a Cysteine Protease Resembling Cpp32-Beta, Interleukin-1-Beta Converting Enzyme, and Ced-3
  2. Juan, T. S. C.; McNiece, I. K.; Argento, J. M.; Jenkins, N. A.; Gilbert, D. J.; Copeland, N. G.; Fletcher, F. A.
  3. Genomics. 1997 40(1): 86-93.
  1. 24.   Targeting Nitric Oxide (No) Delivery in Vivo - Design of a Liver-Selective No Donor Prodrug That Blocks Tumor Necrosis Factor-Alpha-Induced Apoptosis and Toxicity in the Liver
  2. Saavedra, J. E.; Billiar, T. R.; Williams, D. L.; Kim, Y. M.; Watkins, S. C.; Keefer, L. K.
  3. Journal of Medicinal Chemistry. 1997 40(13): 1947-1954.
  1. 25.   Effects of Dehydroepiandrosterone and Calorie Restriction On the Bcl-2/Bax-Mediated Apoptotic Pathway in P53-Deficient Mice
  2. Wang, T. T. Y.; Hursting, S. D.; Perkins, S. N.; Phang, J. M.
  3. Cancer Letters. 1997 116(1): 61-69.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel